Nasopharyngeal Cancer clinical trials at UCLA
1 research study open to eligible people
Showing trials for
BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
open to eligible people ages 18 years and up
The objective of this study is to evaluate the safety, tolerability, and efficacy of BL-B01D1 in patients with Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors.
Duarte, California and other locations
Our lead scientists for Nasopharyngeal Cancer research studies include Jonathan Goldman, MD.
Last updated: